Trimedyne, Inc. is a publicly held, ISO Certified manufacturer of lasers and disposable fiber optic delivery devices cleared for sale by the FDA for use in a variety of minimally invasive surgical applications, including, urology, lithotripsy, orthopedics, spine, arthroscopy, ENT surgery, gynecology, GI surgery, and general surgery. lt br / gt lt br / gt Trimedyne s lasers and minimally invasive, patented, single use, side firing fiber optic devices are used in urology to treat enlarged prostates, and its single use and reusable optical fibers are used to fragment urinary stones in the kidneys, ureter or bladder. Trimedyne s lasers and minimally invasive, patented, single use, side firing laser needles are also used to treat herniated or ruptured discs in the spine, typically in outpatient procedures. lt br / gt lt br / gt Trimedyne s lasers and proprietary, fiber optic laser energy delivery devices are designed to reduce the bleeding and trauma of conventional surgery, reduce or eliminate hospital stays and shorten recuperation time. Trimedyne also owns a broad portfolio of U.S. Patents covering lasers and fiber optic laser energy delivery devices. lt br / gt lt br / gt Trimedyne leases a modern , sq. ft. office and manufacturing facility in Lake Forest, California. lt br / gt lt br / gt Trimedyne s wholly owned subsidiary, Mobile Surgical Technologies, Inc. MST is a fee per case provider of lasers, laser operators, and fiber optic laser energy delivery devices to hospitals, outpatient surgery centers and physicians in Texas and adjoining states, enabling them to avoid buying a laser and hiring and training a technician to operate it. MST is based in Dallas, Texas.
Quote | Trimedyne Inc (OTCMKTS:TMED)
Last: | $4.25 |
---|---|
Change Percent: | 0.0% |
Open: | $4.25 |
Close: | $4.25 |
High: | $4.25 |
Low: | $4.25 |
Volume: | 110 |
Last Trade Date Time: | 03/20/2020 12:01:02 am |
News | Trimedyne Inc (OTCMKTS:TMED)
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUH) (the " Company " of " EGF ") is pleased to announce it has progressed forward and is now very close to acquiring various dispensary targets in British Columbia. ...
Irvine, CA, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- TRIMEDYNE, INC. (OTCPINK “TMED”) today reported its financial results for its quarter ending on December 31, 2019. For the Quarter Ended December 31, 2019, Trimedyne had revenues of $868,000, a decrease of 27...
Message Board Posts | Trimedyne Inc (OTCMKTS:TMED)
Subject | By | Source | When |
---|---|---|---|
TMED: shareholders of Trimedyne, Inc. (TMED) will receive | Renee | investorshub | 03/20/2020 10:13:10 PM |
TMED: effective Nov. 18,2016 a one for 150 | Renee | investorshub | 11/17/2016 1:36:01 PM |
Trading under cash??.way undervalued. | ash111 | investorshub | 12/19/2014 10:29:58 AM |
1 contract news and boooom.imo | ash111 | investorshub | 12/08/2014 5:32:54 PM |
11 times avg. vol | ash111 | investorshub | 12/05/2014 7:09:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Trimedyne Inc Company Name:
TMED Stock Symbol:
OTCMKTS Market:
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUH) (the " Company " of " EGF ") is pleased to announce it has progressed forward and is now very close to acquiring various dispensary targets in British Columbia. ...
Irvine, CA, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- TRIMEDYNE, INC. (OTCPINK “TMED”) today reported its financial results for its quarter ending on December 31, 2019. For the Quarter Ended December 31, 2019, Trimedyne had revenues of $868,000, a decrease of 27...
Irvine, CA, Dec. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- TRIMEDYNE, INC. (OTCBB “TMED”) today reported its financial results for its Fiscal Year ending on September 30, 2019. For the Fiscal Year Ended September 30, 2019, Trimedyne had revenues of $4,524,000, a decr...